Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Sales	$ 37,895	$ 29,512
Cost of sales	9,566	8,827
Gross profit	28,329	20,685
Operating expenses:
Selling, general and administrative	28,636	23,324
Research and development	10,367	8,031
Total operating expenses	39,003	31,355
Loss from operations	(10,674)	(10,670)
Other income (expense), net:
Interest expense	(6)	(6)
Interest and other income	2,508	1,585
Loss before income taxes	(8,172)	(9,091)
Income tax expense	18	9
Net loss	(8,190)	(9,100)
Other comprehensive loss
Unrealized loss on short-term investments	(157)	(45)
Foreign currency translation gain (loss)	6	(3)
Total other comprehensive loss	(151)	(48)
Comprehensive loss	$ (8,341)	$ (9,148)
Net loss per share:
Attributable to common stock, basic	$ (0.2)	$ (0.25)
Attributable to common stock, diluted	$ (0.2)	$ (0.25)
Weighted-average shares used in computing net loss per share:
Attributable to common stock, basic	40,509,646	36,843,087
Attributable to common stock, diluted	40,509,646	36,843,087